Latest Applied genetics Stories
FORT LEE, N.J., May 26, 2011 /PRNewswire/ -- Neurologix, Inc.
AMSTERDAM, May 23, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today the results from studies exploring the role of adeno-associated viral (AAV) vectors for the efficient delivery of short and micro RNA to inhibit disease by RNA interference.
AMSTERDAM, May 19, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext Amsterdam: AMT), a leader in the field of human gene therapy, today provides its non-audited business update in compliance with the EU transparency directive.
Many gene therapy strategies designed to deliver a normal copy of a gene to cells carrying a disease-causing genetic mutation rely on a modified virus to transfer the gene product into affected tissues.
AMSTERDAM, May 10, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, provided today a status update on Glybera (alipogene tiparvovec), its gene therapy product under development for the treatment of lipoprotein lipase deficiency (LPLD). Following the submission of the Day 180 questions at the end of the first quarter to the European Medicines Agency (EMA) as part of Glybera's Market Authorisation Application...
Overcoming the gene silencing barrier opens doors for gene therapy. Lincoln, NE (PRWEB) April 12, 2011 NTC today announced the award of a Small Business Innovation Research (SBIR) Phase II grant award from the National Institute of General Medical Sciences.
FAIRFIELD, Ohio, April 12, 2011 /PRNewswire/ -- "Hello Truth" has meaning for Robert McClendon, DDC's (DNA Diagnostics Center) first Innocence Network exoneree who was freed through forensic DNA testing in 2008.
FAIRFIELD, Ohio, March 24, 2011 /PRNewswire/ -- DDC (DNA Diagnostics Center), the largest provider of private paternity and other DNA testing in the U.S. and worldwide, announced today that genetics and molecular biology expert Dr.
FORT LEE, N.J., March 16, 2011 /PRNewswire/ -- Neurologix, Inc.
A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers.